What is atrial flutter?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Atrial Flutter?

Atrial flutter is a macroreentrant supraventricular tachycardia characterized by organized, regular atrial activity at rates of 250-350 bpm, most commonly involving a reentrant circuit around the tricuspid annulus through the cavotricuspid isthmus. 1, 2, 1

Mechanism and Classification

Atrial flutter operates through a macroreentrant mechanism where electrical impulses circulate around large anatomical barriers in the atrium, creating a continuous loop of activation 3, 4. This differs fundamentally from atrial fibrillation, which involves multiple chaotic wavelets, and from focal atrial tachycardias, which arise from a single point source.

Types of Atrial Flutter

Cavotricuspid Isthmus-Dependent (Typical) Flutter:

  • Counterclockwise (typical): The circuit travels superiorly along the atrial septum and inferiorly along the right atrial free wall through the cavotricuspid isthmus

    • ECG shows predominantly negative "sawtooth" flutter waves in leads II, III, and aVF
    • Positive deflection in V1 with late transition
    • Atrial rate typically 300 bpm (cycle length 200 ms) 1, 2, 1
  • Clockwise (reverse typical): Circuit travels in the opposite direction

    • Positive flutter waves in inferior leads
    • Negative flutter waves in V1
    • Also involves the cavotricuspid isthmus 1, 2

Non-Isthmus-Dependent (Atypical) Flutter:

  • Macroreentrant circuits that do not involve the cavotricuspid isthmus
  • Include perimitral flutter, left atrial roof circuits, and reentry around surgical scars or ablation lesions
  • Often occur in patients with atrial scarring from prior cardiac surgery or catheter ablation 1, 5

Clinical Presentation and ECG Features

The hallmark ECG finding is regular, organized atrial activity without the discrete isoelectric baseline seen between P waves in other atrial tachycardias 1. The ventricular rate depends on AV nodal conduction, typically showing 2:1 conduction resulting in a ventricular rate around 150 bpm in patients with normal AV nodal function 6.

Important caveat: Antiarrhythmic drugs or significant atrial disease can slow the atrial rate below the typical 250-350 bpm range, making diagnosis more challenging 1.

Clinical Context and Associated Conditions

Atrial flutter occurs in similar clinical settings as atrial fibrillation and commonly coexists with it 1. After cavotricuspid isthmus ablation for typical flutter, 22-82% of patients develop atrial fibrillation within 2-5 years of follow-up 1.

Risk factors for subsequent atrial fibrillation include:

  • Prior history of atrial fibrillation
  • Depressed left ventricular function
  • Structural or ischemic heart disease
  • Increased left atrial size 1

Atrial flutter may also result as a complication of antiarrhythmic therapy for atrial fibrillation, particularly with flecainide, propafenone, or amiodarone 1.

Thromboembolic Risk

Patients with atrial flutter carry the same thromboembolic risk as those with atrial fibrillation and require identical anticoagulation strategies 1. This is a critical clinical point that should never be overlooked—the organized nature of atrial flutter does not confer protection against stroke.

Pathophysiology

The substrate for typical atrial flutter involves the cavotricuspid isthmus—the region of atrial tissue between the tricuspid valve annulus and the inferior vena cava 3. This isthmus forms a critical zone of slow conduction that is essential for maintaining the reentrant circuit 3. The presence of anatomical barriers (unlike the functional barriers in atrial fibrillation) makes this arrhythmia particularly amenable to catheter ablation 3, 7.

Related Questions

What is the appropriate management for an asymptomatic patient with atrial flutter?
What is the appropriate management for a patient presenting with atrial flutter?
What are the recommended medications for managing atrial flutter, including rate control, rhythm conversion, maintenance therapy, and anticoagulation?
What is the appropriate management for an 86-year-old patient with atrial flutter?
What is the appropriate management for a 49‑year‑old woman with atrial flutter, including rate control, anticoagulation, and rhythm control strategies?
In a 77-year-old woman with hypertension, heart failure with preserved ejection fraction, and stage IIIb chronic kidney disease who is receiving cefepime and vancomycin for pneumonia and now has encephalopathy manifested by somnolence, confusion, and EEG showing generalized periodic discharges with triphasic morphology, which intervention is most likely to improve her neurological symptoms: discontinue vancomycin, switch cefepime to piperacillin‑tazobactam, administer levetiracetam (Keppra), or start low-dose risperidone?
In a 75‑year‑old woman with persistent sterile pyuria, recent nitrofurantoin therapy, yellow vaginal discharge causing dyspareunia, negative urine culture, and hypertension treated with carvedilol, should vaginal clotrimazole be used?
Which topical anesthetic creams can I prescribe?
Can an adult patient with stable blood pressure and eGFR ≥45 mL/min/1.73 m² start lisinopril and Jardiance (empagliflozin) on the same day?
What topical anesthetic (type, concentration, and application method) is safest and most effective for laser skin procedures, and what are the key safety considerations?
How should I manage mild hyperkalemia (potassium 5.3 mmol/L) in a patient with stage 3a chronic kidney disease (eGFR ≈ 48 mL/min/1.73 m²) who is taking lisinopril?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.